| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.6M | -11.5% |
| R&D Expense | $10.7M | -80.1% |
| SG&A Expense | $24.7M | -1.2% |
| Operating Income | -$15.7M | +72.3% |
| Pre-tax Income | -$29.9M | +43.4% |
| Income Tax | $11K | -94.8% |
| Net Income | -$29.9M | +43.6% |
| EPS (Basic) | -$0.32 | +54.3% |
| EPS (Diluted) | -$0.32 | +54.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.4M | -84.6% |
| Accounts Receivable | $252K | -92.7% |
| Current Assets | $16.0M | -74.8% |
| Total Assets | $16.5M | -74.4% |
| Current Liabilities | $7.2M | -69.4% |
| Long-term Debt | $2.8M | -79.6% |
| Total Liabilities | $8.1M | -84.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.1M | +54.1% |
| Investing Cash Flow | $3K | +121.4% |
| Financing Cash Flow | -$16.8M | -122.6% |
| Stockholders' Equity |
| $8.5M |
| -34.3% |